The components of total variation-biological, inter-and intra-individual, and analytical-of plasma lipids, lipoprotein lipids, and apolipoproteins A-I and B have been determined in a population of 44 healthy women, ages 18-35 years. Blood was sampled three separate times at three-month intervals, with no restrictions on diet or physical activity during these periods. The greatest inter-individual variances were observed for high-density lipoprotein (HDL)-cholesterol, HDL2-cholesterol, and total plasma cholesterol. Triglycerides had the highest intra-individual variance (CV 22%). The percentage of inter-and intra-individual variances of apolipoprotein A-I concentrations were more reflective of total HDLand HDL2-cholesterol content than of HDL.3-cholesterol.
outpatients. The inclusion criteria were that the subjects be women between the ages of 18 and 35 years, be at least 12 weeks postpartum, be within 20% of ideal body weight [as determined from the Metropolitan Life Insurance tables (3)1, be non-smokers, and have regular menstrual cycles. Because this population was being used as a control group for an oral-contraceptive study, they were either using a non-hormonal contraceptive method or were surgically sterile, with intact ovaries. During this period, they were instructed to maintain their usual diets and lifestyles. Participants had baseline values for plasma cholesterol 2400 mgIL, plasma triglyceride 1450 mgIL, and plasma glucose s1200 mg/L as determined by routine clinical testing. Each volunteer (they were at five different study sites) was sampled on three separate occasions (zero time, three months, six months). Fifty women started the protocol; results for 44 women were analyzed, the remaining six having had only one or two visits. There was no difference in the mean concentrations of any analyte between the women whose measurements were used for analysis and the women with fewer than three visits.
Specimen Processing
All subjects fasted for 12 h before blood sampling. The specimens were collected into EDTA-containing tubes, and the plasma, separated by centrifugation (2000 X g, 20 mm, 4#{176}C) within 1 h, was aliquoted into several tubes and stored at -70 #{176}C until overnight shipment on solid CO2 to our laboratory. They were thawed only once, for analysis. Apolipoprotemn A-I was determined by a radioimmunoassay described recently (10). Apolipoprotein B was determined according to Schonfeld et al. (11) . LDL used as standard and for iodination was prepared by zonal ultracentrifugation (12), then iodinated by the Chloramine T method (13). Before each assay, LDL was repurified on a column of Sephadex G-50. Antiserum was diluted so as to bind 50-60% of the tracer. The total volume of standards or diluted plasma specimens, iodinated LDL, pH 8.6 barbital buffer (50 mmollL, containing 1.0 mmol of EDTA and 20 g of bovine serum albumin per liter), and antiserum was (15) and other routine statistical methods were used (16). Inter-individual, intra-individual, and laboratory effects were assumed to be random with a mean of zero and variances of inter-individua1, intra-individual, and 21aboratory' respectively. The laboratory qualitycontrol data were used to estimate Qualitycontrol assessment of total cholesterol, total triglyceride, and HDL-cholesterol measurements was performed daily throughout this study with use of quality-control pools from the Centers for Disease Control, Atlanta, GA, then analyzed by months or by quarters. The performance of HDL3-cholesterol and apolipoproteins A-I and B was monitored with laboratory-prepared pools that were stored in aliquots at -70 #{176}C and only thawed once. When available, qualitycontrol pools from the Centers for Disease Control were used as well. For each laboratory variable, the mean and variance of each plasma pool for each month or quarter were estimated. These estimates were then combined across plasma pools and the study period to yield an estimate of the O2laboratory.
Analytical Procedures

Statistical Methods
Analysis of variance
The data from 44 individuals measured three times were used to estimate the variance components among The proportion of the total variance attributable to inter-individual, intra-individual, and laboratory effects was estimated for each variable. To identify possible outliers, the mean and SD were calculated for each analyte and subject for the three visits. From these data, the mean and SD for the entire population were calculated. If SD in an individual exceeded 3 SD of the population mean, the value farthest away from the mean value in this individual was identified as an outlier and excluded from further analysis.
Results
The mean concentrations of the analytes in the study group were compared with age-and sex-matched values reported in the Lipid Research Clinics (LRC) Prevelance Study (17) (Table 1) . Average plasma cholesterol and triglyceride concentrations in the sample of women were approximately at the 50th percentile, and mean HDLcholesterol concentrations were at the 75th percentile of the LRC population. Concurrently, calculated LDL-cholesterol concentrations were between the 25th and 50th percentiles of the LRC population. Data for comparison of HDL3-and HDL2-cholesterol and apolipoprotein A-I and B concentrations in age-and sex-matched populations were not available.
The performance of the laboratory during the study was judged by its quality-control data on pooled specimens of human plasma. The laboratory CV includes specimen processing and analytical variation, which consists of withinand between-assay variability ( i.e., they vary widely within the population studied, but fluctuate slightly within an individual upon repeated analysis. HDL-cholesterol and HDL2-cholesterol had the greatest individuality within this population of healthy women. In contrast, if the ratios are high, the concentrations of these plasma constituents vary widely in an individual, as was observed for apolipoprotein B and triglycerides. Knowledge of intra-individual and analytical variation is important for interpreting laboratory results. From our data the CVI,, which consists of intra-individual and laboratory variation (24, 25), can be calculated for single or repeated determinations. Table 3 illustrates that, for analytes with a low laboratory CV, multiple determinations are very effective in decreasing the variability around the mean biological concentration.
Discussion
This would have a direct impact on the interpretation of total cholesterol or LDLcholesterol measurements, in that misclassiflcations for CHD could be reduced.
